Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts
about
Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signalingThe low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activityI-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways.A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptorWNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancerRegulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 OncoproteinsPhosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathwaysInduction of homologue of Slimb ubiquitin ligase receptor by mitogen signalingWnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5.Dkk1 stabilizes Wnt co-receptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation.Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinaseDiverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells.Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma.High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/β-catenin target gene, CDC25A.A Wnt survival guide: from flies to human disease.Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo.Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3Wnt2 inhibits enteric bacterial-induced inflammation in intestinal epithelial cellsRaphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16.Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancerMyeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth.Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3.Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells.Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastasesSuppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferationBortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a.Mechanisms of RAS/β-catenin interactions.Secreted frizzled related protein 1 protects H9C2 cells from hypoxia/re-oxygenation injury by blocking the Wnt signaling pathway.Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells.Cooperative folding and ligand-binding properties of LRP6 beta-propeller domains.R-spondin1 synergizes with Wnt3A in inducing osteoblast differentiation and osteoprotegerin expression.Analysis of endogenous LRP6 function reveals a novel feedback mechanism by which Wnt negatively regulates its receptor.Wnt/Frizzled signaling in Ewing sarcoma.Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts.Inhibition of HOS expression and activities by Wnt pathway.Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation.BMPs, FGF8 and Wnts regulate the differentiation of locus coeruleus noradrenergic neuronal precursors.
P2860
Q22010178-6A345F2A-A576-465F-B8BC-2F7E7705FD8CQ24299312-3C6DB78B-1B3F-4C21-A24E-BF169F88BF5BQ24305168-D0FF5A50-EA6E-4989-B7F0-CCE882929D39Q24313393-87025F44-BD42-47DC-ACA4-A4C0360B59A5Q24338737-C4DA6B3E-48F5-4E9E-97E9-67CA22905DDCQ26795741-3BD74D68-FF10-4D43-BF23-8AEFCA2BB574Q28177635-27DCD584-7331-4DCC-9805-331CE48621B1Q28216569-4696773B-5323-477C-BEAD-AB7F8CD93FE5Q28589685-19594483-1DA6-4334-B1E1-B98A8DEF4209Q33603037-C4E574A4-2CA5-4A25-B515-5F46B89735B7Q33618690-801897F6-CD83-40C7-97E8-61DE490B58BCQ33960787-C35BA812-0BCE-4680-9C10-432D64010737Q34147510-F7A9677F-6F62-40B4-8705-8BC6F93A8439Q34976628-FD5D2BD2-4D2F-4DA9-9F83-8A0391982146Q35049311-30BAE49C-2437-46F1-AC89-8D712B091086Q35073590-78E313F2-B45B-40A6-91E2-86C01DD85FCDQ35243349-E8332900-1F9A-4AA8-9B95-B3007F657E42Q35542572-0DB7B73F-4688-4BD3-B52F-71CB9B86FE9FQ35804729-7C00348B-01CA-469C-A26A-6F1BF49313D8Q35844058-86E74E3E-F43C-44A3-820A-26544C7D7258Q36536565-E14B77D4-09EC-4CEA-BD4E-70C44213455FQ36732811-7E4629E0-ECAB-4DE4-839E-0569C171A9AEQ36742501-C0652466-08DB-4536-AB74-44CF1D985AB8Q36935598-382B6C40-41A0-4025-8E5C-4BE62C044587Q36998222-C1762EA4-58FC-4D1B-9E6E-754839F77836Q37066448-0DE0461A-2A89-49AC-A57D-A445500DC907Q37086749-0DF67329-E578-4BF9-9FC9-2EC95FE266D7Q37176560-C98D60E7-AAFF-4541-9CCD-28D0291BDA0FQ37260268-6A6557CE-A23D-4BC3-AB25-1BDDA2771C49Q38088654-3A025FC9-B3AC-4A64-9A03-014B4EA3E154Q38780532-9912813E-B91D-496C-A3C8-2C6B0D977CC6Q39512092-DE4CC6CE-9B1D-4E5C-8DE3-70660E7465B1Q39865463-31FEC95B-5839-4B8D-9479-AE578F4D9341Q40017828-A7942E27-E869-41E8-BBAA-5477537B6622Q40094304-33F50AF7-66F0-4137-AE35-90B90466E26CQ40533011-FFAFE112-6A4D-4A6A-8343-91C8A03F046AQ40718642-CF1DA526-C81D-4821-8A2B-904FBCD49AEAQ40750211-6470377E-0E4F-4106-99E9-52BA39BA2F9DQ42803654-D40AA498-94FF-4AEB-B5B8-E30B638E780BQ48417375-FB51ACAA-C101-43B5-9CBA-F4823FA706B6
P2860
Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts
description
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1998
@ast
im Mai 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/05/28)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/05/28)
@nl
наукова стаття, опублікована в травні 1998
@uk
научни чланак (објављен 1998/05/28)
@sr
name
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@ast
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@en
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@nl
type
label
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@ast
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@en
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@nl
prefLabel
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@ast
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@en
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@nl
P2093
P3181
P356
P1433
P1476
Characterization of Wnt-1 and ...... pathways in NIH3T3 fibroblasts
@en
P2093
S. A. Aaronson
S. S. Wu-Morgan
P2888
P304
P3181
P356
10.1038/SJ.ONC.1201797
P407
P577
1998-05-28T00:00:00Z
P5875
P6179
1017476080